methylation Apr 12, 2022 New Epigenomic Biomarker Could Predict CAR T-Cell Therapy Resistance in Advanced Childhood Leukemia Premium Apr 5, 2022 Singlera Genomics, Astellas Pharma Partner to Study Drug Reactions Mar 31, 2022 New Esophageal Cancer Tests on Horizon as Hopkins Spinout Capsulomics Preps Clinical Launch Premium Mar 2, 2022 Inherited Cancer Risk Detected in Significant Subset of Wilms Tumor Cases Jan 7, 2022 Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom Premium Jan 5, 2022 Nucleix Raises Additional $22M Nov 2, 2021 Saga Diagnostics, AstraZeneca Ink Digital PCR Assay Development Deal Aug 16, 2021 Advanced Gastric Cancer Multiomic Analysis Reveals New Potential Therapeutic Targets Jul 23, 2021 Adding Chemo to Radiation Therapy Improves Outcomes for Certain Medulloblastoma Patients, Study Finds Jun 23, 2021 Liquid Biopsy Startup Adela Launches With $60M Series A Financing Round Jun 3, 2021 Nucleix, MD Anderson Partner on Methylation-Based Lung Cancer Dx Tests May 26, 2021 Acute Lymphoblastic Leukemia Study Explores Role of DNA Methylation in Outcomes, Treatment Apr 15, 2021 Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches Premium Apr 1, 2021 Guardant Health Receives New York State Approval for Guardant Reveal MRD Test Feb 17, 2021 Exact Sciences Sketches Out Strategy for End-to-End Cancer Testing With Ashion Acquisition Premium Feb 9, 2021 Spanish Cancer Company Universal Dx to Commercialize Methylation Method for Lung Cancer Detection Premium Jan 11, 2021 Grail Inks Deals With Amgen, AstraZeneca, Bristol Myers Squibb for MRD Test Development Oct 16, 2020 Pancreatic Cancer Subtype With Poor Outcomes Shows Low Methylation, High Interferon Signature Aug 26, 2020 Freenome Closes $270M Series C Financing to Support Early Cancer Detection Trial Jul 1, 2020 AnchorDx Demonstrates Liquid Biopsy DNA Methylation Test for Early Cancer Detection Premium Load More Breaking News In Brief This Week: Gilead Sciences, Arcus Biosciences, Verismo Therapeutics, Caris Life Sciences Pyxis Oncology Gets FDA Permission to Start Phase I Trials of Anti-EDB Drug, Immunotherapy FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round
